Advertisement
U.S. Markets open in 5 hrs 54 mins

Cognition Therapeutics, Inc. (CGTX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.4998+0.0116 (+2.38%)
At close: 04:00PM EST
0.5099 +0.01 (+2.02%)
After hours: 07:30PM EST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
0
0
0
0
0
Operating Expense
32,037
25,919
21,334
11,151
6,552
Operating Income
-32,037
-25,919
-21,334
-11,151
-6,552
Net Non Operating Interest Income Expense
-28
-27
-28
-893
-1,751
Other Income Expense
983
158
-35
328
464
Pretax Income
-31,082
-25,788
-21,397
-11,716
-7,839
Net Income Common Stockholders
-31,082
-25,788
-21,397
-16,248
-12,073
Diluted NI Available to Com Stockholders
-31,082
-25,788
-21,397
-16,248
-12,073
Basic EPS
-0.79
-0.86
-0.91
-3.13
-0.56
Diluted EPS
-0.79
-0.86
-0.91
-3.13
-0.56
Basic Average Shares
28,899
30,029
23,640
5,191
21,371
Diluted Average Shares
28,899
30,029
23,640
5,191
21,371
Total Operating Income as Reported
-58,714
-50,724
-43,551
-28,598
-17,407
Total Expenses
32,037
25,919
21,334
11,151
6,552
Net Income from Continuing & Discontinued Operation
-31,082
-25,788
-21,397
-11,716
-7,839
Normalized Income
-30,887
-25,788
-21,397
-14,368
-7,909
Interest Expense
28
27
28
893
1,751
Net Interest Income
-28
-27
-28
-893
-1,751
EBIT
-31,054
-25,761
-21,369
-10,823
-6,088
EBITDA
-30,798
-25,509
-21,134
-10,730
-5,990
Reconciled Depreciation
256
252
235
93
98
Net Income from Continuing Operation Net Minority Interest
-31,082
-25,788
-21,397
-11,716
-7,839
Total Unusual Items Excluding Goodwill
-195
-
0
2,652
70
Total Unusual Items
-195
-
0
2,652
70
Normalized EBITDA
-30,603
-25,509
-21,134
-13,382
-6,060
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0